iRhythm Technologies Inc (STU:I25)
€ 79.5 -2 (-2.45%) Market Cap: 2.51 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 37.70 GF Score: 68/100

iRhythm Technologies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 09:00PM GMT
Release Date Price: €39.6 (-0.50%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, and thank you for joining us for the first day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley.

It's my pleasure to have iRhythm with us today. Doug Devine, Interim CEO and CFO; and Dan Wilson, EVP Strategy and Corporate Development. Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any question, please reach out to your Morgan Stanley sales representative.

And with that, Doug, Dan, thank you for joining us today.

Douglas J. Devine
iRhythm Technologies, Inc. - COO, CFO & Secretary

Hi, Cecilia.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot